Active Ingredient History

NOW
  • Now
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis by the same mechanism as rHuEpo and is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy. Darbepoetin is marketed by Amgen under the trade name Aranesp.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$24.0875 - $3694.9700

Australia

$26.5560 - $291.1872
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

aranesp | aranesp sureclick | darbepoetin | darbepoetin alfa | darbepoetin alfa,recombinant | darbepoietin | darbepoietin alpha | darbopoetin | krn321 | mk2578 | nesp | pegylated darbepoetin beta

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue